• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Syncom Formulations (India) Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3544.0
  • ISIN : INE312C01025
16.46 -1 (-2.95%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    16.32

  • Today’s High

    17.50

  • Open

    17.00

  • Perv Close

    16.96

  • 52W Low

    10.95

  • 52W High

    27.90

Key Indicators

  • P/E(TTM)

    40.12

  • Mar.Cap (₹Cr.)

    1,547.24

  • Div & Yield %

    0.00

  • Book Value(₹)

    3.32

  • Debt-Equity Ratio

    -2.95

  • AGM Date

    28-Mar-2025

  • EPS

    0.41

  • P/E Ratio

    40.12

Financials Ratios

  • Debt-Equity Ratio

    0.29

  • Mar.Cap (₹Cr.)

    1,547.24

  • RONW (%)

    9.30

  • ROCE (%)

    10.91

Score Board

  • Equity (₹ in Cr.)

    94.00

  • BV (₹)

    3.30

  • Sales( ₹ in Cr.)

    258.36

  • NP (in Cr.)

    23.08

  • NP Var(%)

    16.0

  • Div%

    0.0

  • CPS (₹)

    0.30

  • EPS (₹)

    0.20

  • Traded Value (₹ in Lakhs)

    1,546.30

  • 52 Week High

    27.90

  • 52 Week Low

    10.95

  • Price BSE

    16.0

  • Price NSE

    16.00

  • Market Capital( in Cr.)

    1,546.30

  • P/C Ratio

    54.10

  • P/E Ratio

    65.20

  • Price Vs.BV

    0.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 258.36 224.64 219.66 244.81 205.51 186.77
Excise Duty 254.90 222.88 217.82 239.32 200.08 181.97
Net Sales 258.36 224.64 219.66 244.81 205.51 186.77
Other Income 13.10 14.61 11.99 7.14 5.22 5.08
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 271.46 239.25 231.66 251.95 210.73 191.85
EXPENDITURE :
Raw Materials 254.90 222.88 217.82 239.32 200.08 181.97
Power & Fuel Cost 254.90 222.88 217.82 239.32 200.08 181.97
Employee Cost 35.06 25.87 22.16 19.58 16.29 15.58
Other Manufacturing Expenses 3.25 2.68 2.00 1.46 1.66 1.85
Selling & Administrative Expenses 28.52 26.21 28.62 18.77 13.58 16.82
Miscellaneous Expenses 3.25 2.68 2.00 1.46 1.66 1.85
Less : Pre-operative Expenses Capitalised :
Total Expenditure 239.68 212.70 205.50 211.27 193.39 179.18
Operating Profit 8.12 8.15 6.31 5.61 5.63 5.07
Interest 4.45 3.13 1.93 0.36 0.55 0.22
Gross Profit 31.76 26.57 26.18 40.70 17.29 12.68
Depreciation 4.72 4.54 3.95 4.03 4.06 4.00
Profit Before Tax 31.76 26.57 26.18 40.70 17.29 12.68
Tax 7.55 6.68 6.43 10.29 4.43 3.31
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.55 -0.15 0.14 0.23 -1.40 -1.86
Reported Net Profit 23.62 20.07 19.79 29.17 14.25 11.09
Extraordinary Items 31.76 26.57 26.18 40.70 17.29 12.68
Adjusted Net Profit 23.62 20.07 19.79 29.17 14.25 11.09
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 2.59 0.00 0.00 0.00
P & L Balance carried down 23.62 20.07 19.79 29.17 14.25 11.09
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 3.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.03 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.32 0.24 0.26 0.37 0.18 0.14
Book Value 0.00 0.00 2.59 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 2.59 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    50.57%

  • Public Share Holding

    49.43%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 83,061,125 8.84 83,061,125 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 392,286,474 41.73 392,286,474 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 475,347,599 50.57 475,347,599 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,239,348 0.13 1,239,348 7
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 17,332 0.00 17,332 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,256,680 0.13 1,256,680 9
2] Non Institution
Bodies Corporate 10,246,774 1.09 10,246,774 260
Clearing Members 428,219 0.05 428,219 15
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 16,523,814 1.76 16,421,314 1,966
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 10,088,211 1.07 10,088,211 1,842
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 56,432,164 6.00 56,432,164 127
Individuals holding nominal share capital up to Rs. 1 lakh 367,125,328 39.06 364,680,648 485,287
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,551,211 0.27 2,551,211 1
Sub Total 463,395,721 49.30 460,848,541 489,498
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 940,000,000 100.00 937,452,820 489,520

Company Background

Syncom Formulations (India) LtdPharmaceuticals - Indian - Formulations

  • Syncom Formulations (India) Ltd
  • BSE Code : 3544.0
  • ISIN : INE312C01025

  • Incorporation Year

    1988

  • Registered Office

    7 Niraj Indl Estate Andheri(E)
    Off Mahakali Caves Rd, Mumbai,
    Maharashtra-400093

  • Telephone

    91-22-30887744

  • FAX

    91-22-30887755

  • Chairman

    Kedarmal Bankda

  • Managing Director

    Vijay Shankarlal Bankda

  • Company Secretary

    Vaishali Agrawal

  • Auditor

    Sanjay Mehta & Associates

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Ankit Consultancy Pvt Ltd
    Plot No. 60,
    Electronic Complex,Pardeshipura
    Mumbai - Indore - 452010

Syncom Formulations (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Syncom Formul. 16.45 271.46 258.36 40.12 10.32
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92